United Laboratories International (HKG:3933) unit Zhuhai United Laboratories Zhongshan Branch obtained approval in China for certain marketing applications for its Tadalafil tablets.
The National Medical Products Administration granted three applications for the drug for erectile dysfunction and ED associated with benign prostatic hyperplasia, according to a Thursday filing.